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Relationship between the expression of vascular
endothelial growth factor and the density of dendritic
cells in gastric adenocarcinoma tissue
H Saito, S Tsujitani, M Ikeguchi, M Maeta and N Kaibara
First Department of Surgery, Tottori University School of Medicine. 36-1 Nishi-cho. Yonago. 683 Japan
Summary It has been reported that decreased numbers of dendritic cells (DCs) are correlated with poor prognosis in some types of
malignancy, such as gastric cancer. However, factors that determine the density of DCs have not been characterized. It was recently reported
that vascular endothelial growth factor (VEGF) inhibits the functional maturation of DCs from CD34- precursors. In this study, we analysed the
relationship between the expression of VEGF and the density of DCs in gastric carcinoma tissues by immunohistochemical staining. The
extent of infiltration by DCs was graded from marked to slight on the basis of the mean densities of DCs. The prognosis of patients with
marked infiltration was significantly better than that of patients with slight infiltration among patients who had undergone curative resection.
Multivariate analysis showed that infiltration by DCs was an independent prognostic indicator. Furthermore, there was an inverse correlation
between the density of DCs and the expression of VEGF. Our results suggest that expression of VEGF might be associated with tumour
progression and poor prognosis not only because VEGF stimulates angiogenesis, but also because it allows tumours to escape from attack
by the immune system in patients with gastric carcinoma.
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Dendritic cells (DCs) plax an important role in the presentation of
tumour antigens and in the induction ofspecific immune responses
to carcinoma. Thus. the infiltration of tumours by DCs is thought
to reflect the local immune response (Tsujitani et al. 1990). We
reported previously that the survival time of patients with
adsvanced gastric cancer was correlated with the density of DCs
that were positive for S-100 protein (Tsujitani et al. 1987). Similar
results hav-e been obtained by other groups who studied malignan-
cies of the lung (Miyake et al. 1992). nasopharvnx (Nomori et al.
1986). oesophagus (Matsuda et al. 1990). large intestine (Ambe et
al. 1989) and uterine cerv-ix (Nakano et al. 1989). However. the
mechanism responsible for the control of the densitv of DCs
remains unclear.
Vascular endothelial growth factor (VEGF) acts as a mitogen for
endothelial cells in *-itro. and it is a potent angiogenesis-promoting
factor in viso (Ferrara et al. 1989: Gospodarow-icz et al. 1989). It
has been isolated from a -ariety of tumorgenic and non-trans-
formed cell lines and is thought to be a major regulator of tumour
angiogenesis (Leung et al. 1989). It was reported recentlI that
VEGF produced by human tumours inhibits the functional matura-
tion of DCs from CD4- precursors (Gabrilovich et al. 1996a).
Thus. we postulated that VEGF might influence the density ofDCs
that express S-100 protein in human gastric adenocarcinoma.
In the current study. both the expression ofVEGF and the infiltra-
tion by DCs were examined in 140 patients with gastric adenocarci-
nomaby an immunohistochemical miethod toesaluate the correlation
between the expression ofVEGF and infiltration by DCs.
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MATERIALS AND METHODS
Patient population and tumours
Specimens of primarv gastric adenocarcinomas were obtained
from 140 patients who had been treated surgicall at the First
Department of Surgerv. Tottonr Universitv Hospital. between 1981
and 1995. There were 78 male and 62 female patients. Their ages
ranged from 31 to 91 years (mean 62.3 years).
The clinicopathological findings were determined according to
the rules set out by the Japanese Research Societv for Gastric
Cancer (Japanese Research Society for Gastric Cancer. 1995).
Fomr-eight tumours were categorized as stage I. 38 as stage IL. 27
as stage III and 27 as stage IV. Fifty-three tumours were associated
with lymph node metastasis. whereas 87 were not: 11 tumours
were associated with peritoneal metastasis. whereas 129 w-ere not:
and six tumours were associated with liver metastasis and 134
were not.
Immunohistochemical staining
Detection andcounting ofdendritic cells
Four-micron sections were dewaxed in xylene. dehydrated in
ethanol and heated in a microwase oven (700 W) for 10min to
retrieve antigens. Endogenous peroxidase activitv was blocked by
incubation of samples in a 3%7 solution of hydrogen peroxide in
methanol. After washing with phosphate-buffered sahine (PBS). the
samnples were incubated oxernight with a mouse monoclonal anti-
body against S-100 protein (Nichirei. Tokyo. Japan: dilution.
1:200). The samples were then incubated w-ith Envision-labelled
polymer reagent (Dako. Copenhagen. Denmark) for 60 min at room
temperature. Envision-labelled polymer reagent is a peroxidase-
labelled polymer conjugated to goat anti-rabbit and goat anti-mouse
15731574 H Saito et al
Figure 1 DCs that were positive for S-100 protein in gastric
adenocarcinoma. DCs were scattered among cancer cells and they formed
clusters in the cancerous stroma in some areas (magnification x 340)
immunoglobulins in Tris-HCl buffer containing carrier protein and
an antimicrobial agent. The reaction products were visualized with
diaminobenzidine as the chromogen. and the sections were counter-
stained with methyl green. Normal mouse immunoglobulin G (IgG)
was used instead of the primary. antibodies for negative controls.
The numbers of DCs that were positive for S-100 protein were
counted in primary tumours. including adjacent gastric mucosa. The
stained sections were screened at x100magnification (x10 objective
lens and xlO ocular lens) under a light microscope (VANOX-S.
Olympus. Tokxo) to identify the five regions ofthe section with the
highest number of DCs. The image was visualized on a computer
display (Macintosh 7500/100. Apple Computer. Cupertino. CA.
USA) through a colour video camera module (XC-003. Sonv.
Figure 2 The expression of VEGF in gastric adenocarcinoma. VEGF was
mainly lcalized in the cytoplasm of the carcinoma cells (magnification x 340)
Tokvo. Japan) and colour image freezer (AE-6905C. ATTO. Tokyo.
Japan). DCs were counted in these areas at x200 magnification (x20
objective lens and xlO ocular lens) and their axerage numbers
recorded. The visualized area on the displayxwas determined to be
0.075 mm'. Therefore. DCs were counted only in tumour tissues
and in gastric mucosa from which penrpheral nernes x-ere absent.
Two observers (S.T.. H.S.) did the counting. and the mean value was
used for the analysis.
Expression of VEGF
The expression of VEGF wxas detected Awith polyclonal antibodies
against VEGF (Santa Cruz BiotechnologN. Santa Cruz. CA. USA:
Table 1 Correlations between infiltration by DCs, expression of VEGF and clinicopathological features
Infiltration by dendrific cells Expression of VEGF
Marked infiltration/ P-value Posive casesl P-value
tested tumours tested tumours
Depth of invasion
T1/T2 33/55 (60%h) P< 0.01 14/55 (25.5°0o) P< 0.001
T3/T4 29/85 (34.1%) 56/85 (65.900)
Lymph node metastasis
Negative 43/87 (49 4%) NSa 36/87 (41.40o) P< 0.05
Positive 19/53 (35.8%/O) 34/53 (64.200)
Peritonea] metastasis
Negative 57/129 (44.2%) NS 61/129 (47.30O) NS
Positive 5/11 (45.5%) 9/11 (81.8h0)
Liver metastasis
Negative 60/134 (44.8%) NS 67/134 (50%o) NS
Positive 2/6 (33.3°o) 3/6 (50°o)
Lymphatic vessel invasion
Negative 37/65 (56.9%o) P < 0.01 23/65 (35.4°o) P < 0.01
Positive 25/75 (33.3%0) 47/75 (62.700)
Blood vessel invasion
Negative 40/67 (59.70) P < 0.001 20/67 (29.9°o) P < 0.001
Positive 22/73 (30.1o1) 50/73 (68.50o)
aNS not significant.
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Table 2 Association of various factors with overall survival determined by the Cox's proportional hazards model
Prognostic factors P Hazard ratio
Agea 0.5499 1.005
Gender (male or female) 0.8946 0.975
Tumour sizea 0.0161 1.071
Histology (well or poorty): 0.0997 0.694
Depth of invasion (t,-t,,)c 0.0989 0.807
Lymph node metastasis (n.-n3): 0.0641 1.281
Lymphatic vessel invasion (ty,ly3)e 0.6901 1.043
Blood vessel invasion (v0-v)f 0.2152 0.858
Dendribc cell infiltration (marked or slight)g 0.0134 1.598
aContinuous variables. DWell, papillary or tubular adenocarcinoma; poorty. poorty differentiated or undifferentiated
adenocarcinoma. or signet ring cell carcinoma. ct,I tumour has invaded lamina propria or submucosa: t2. tumour
has invaded the muscularis propria or the subserosa; t3, penetrating the serosa; t%, invading adjacent organs. :n,.
no regional tymph node metastasis; n , n2 and n3, metastasis in groups 1, 2 and 3 lymph nodes respectively.
eLymphatic invasion: tyO4y3. grade of tymphatic vessel invasion. Blood vessel invasion: v -v3. grade of blood
vessel invasion. marked infiltration > 15 cells. slight infiltration s 15 cells.
LI Marked (n=55)
7 L~- Slight (n=65)
-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
50 _
P <0.01
a
coefficient. Differences between survival curnes were examined
by the greneralized Wilcoxon test. These curves were constructed
by the Kaplan-Meier method. Multivariate analysis of prognostic
factors for overall surnival wk-as made using Cox's proportional
hazards model. The accepted level ofsignificance was P < 0.05.
RESULTS
Histological findings
Figure 3 Kaplan4
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1 2 3 4 5 6 Dendritic cells that were positive for S-100 protein were scattered
Years after gastrectomy among cancer cells and they formed clusters in the cancerous
stroma in some areas (Figure 1). The number of DCs ranged from
Meier survival curves for 120 patients who had undergone 1.8 to 71.8. with a mean value of 15.0 (s.d. 8.5). The tumours ere
y. subdivided according to the density of DCs that were divided into two groups based on the mean Xalue as followrs
rotein (marked, > 15 DCs; slight. < 15 DCs). The
ts with marked infittration by DCs was significantty better marked infiltration > 15 DCs. slight infiltration < 15 DCs.
s with slight infiltration VEGF was localized mainly in the cytoplasm of the carcinoma
cells (Figure 2). Tumourcells that were strongly irmmunopositiv-e for
VEGF were observed at the invasihe front more often than in the
These antibodies were raised against a synthetic centre of tumours. Weakly positive immunostaining for VEGF was
-esponded to amino acid residues 1-20 of human seen on normal gastric mucosa and in some endothelial cells. The
bodies recognized the 165-. 189- and 121-residue percentage of immunoreactive cells on a total of 1000 neoplastic
of VEGF. Envision-labelled polymer reagent was cells ranged from 0 to 80.1 with a mean xalue of 16.0 (s.d.. 16.6).
unoreaction. Normal rabbit IgG was used instead The positive cases were detected in 70 (50.0%7 ) tumours.
of the primary antibodies for negative controls. Smooth muscle in
each section serned as a positive control as smooth muscle cells
hax e been shown to express VEGF. The expression of VEGF was
assessed according to the percentage of immunoreactive cells on a
total of 1000 neoplastic cells. The method for counting the positive
cells was similar to that for counting DCs. Moreoxer. immuno-
reactivity,was graded as follows: positive. more than 10%c of carci-
noma cells were stained: negatix e. no detectable expression or less
than 10%7 of carcinoma cells were stained.
Statistical analysis
The association offactors w-as evaluated by the chi-square test and
Fisher's exact probability test. The sianificance of differences
among means was determined by the Mann-Whitney (for two
categones) and the Kruskal-Wallis (for three or more cateoories)
tests. The correlation between the expression of VEGF and the
density of DCs was analysed usinc the Spearman rank correlation
Correlations between infiltration by DCs, expression of
VEGF and clinicopathological features
Correlations between the infiltration by DCs and the expression of
VEGF and different clinicopathologrical variables are show-n in
Table 1. The infiltration by DCs and the expression ofVEGFA ere
evaluated in relation to six clinicopathological features: depth of
invasion: lymph node metastasis: peritoneal metastasis: liver
metastasis: invasion of blood -essels: and invasion of lymphatic
vessels. The extent of infiltration by DCs was significantly corre-
lated with depth of invasion. invasion of lymphatic vessels and
invasion of blood vessels. The expression of VEGF was signifi-
cantly correlated with depth of invasion, lymph node metastasis.
invasion of lymphatic vessels and invasion of blood vessels.
Although gastric carcinomas with peritoneal metastasis w-ere more
frequently positive for VEGF than those without peritoneal
metastasis. the difference was not statistically significant.
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Figure 4 The correlation between the expression of VEGF and the density
of DCs. The expression of VEGF was inversely related to the density of DCs
in gastric carcinoma (r = -0.494. P < 0.0001)
Correlations between infiltration by DCs, expression of
VEGF and prognosis
The 5-vear sunrixal rate of our patients wvas 100%l for those %vith
stace I disease. 78.1 %7c for stage II. 50.5% for stage III and 1. 1%lW
for stare IV. The densitx of DCs correlated with prognosis in both
stage LI and stage III. but did not correlate in stare I or IV (data not
showxn). Among the patients in this studv. 120 underxxent curatixe
gastrectomN. Cnrteria for putatixely curative resection included the
complete remoxal of the primary gyastric tumour. dissection of
regional l-mph nodes and the absence of any residual macroscopic
tumour. These patients had no metastasis in the liv-er. peritoneum
or distant organs at the time of surgery. The prognosis of patients
x-ith marked infiltration by DCs was significantlv better than that
of patients with slirht infiltration (Figure 3.) In addition. the prog-
nosis ofpatients whose tumours did not express VEGF A as signif-
icantlx better than that ofpatients whose tumours expressed VEGF
(data not shown).
Muftivariate analysis
To assess w-hether the infiltration by DCs represented a prognostic
parameter. w-e used Cox's proportional hazards model. The covari-
ates included gender. age. tumour size. histological classification.
depth of invasion. lymph node metastasis. lymphatic xessel inxa-
sion. blood vessel invasion and infiltration by DCs. Multixariate
analxsis showed that both the infiltration by DCs and tumour size
were independent prognostic indicators (Table 2).
Correlation between expression of VEGF and
infiltration by DCs
The expression of VEGF was inversely related to the density of
DCs in castric carcinoma (r = -0.494. P < 0.0001) (Figure 4).
Moreover. the number of S-100 protein-positixe DCs in VEGF-
negatixe tumours Ax as si nificantlv higher than that in VEGF-posi-
tive tumours in patients with gastric carcinomas at stages I. II and
III. Ex en at stage IV. the number of S-lOO protein-positive DCs in
VEGF-neaative tumours wxas higher than that in VEGF-positive
tumours. but the difference was not significant. In both VEGF-
negative tumours and VEGF-positix e tumours. there wxere.
Table 3 Correlation between the expression of VEGF and infiltrabon by
DCs
Stage Counts of infiltration by DCs P-value
VEGF-positive VEGF-negative
Stage 12.5 4 (n= 11) 20.6-11 (n= 37) P<0.01
Stage 11 9.5 +4.4 (n = 22) 16.6 t6.6 (n = 16) P < 0.01
Stagell 10.9 46.3 (n= 15) 18.7 7 (n= 12) P< 0.01
Stage IV 11.6 +4.3 (n =22) 17.3 t10.2 (n = 5) NSa
Total 10.9 4.8(n=70) 19.1 +9.5(n=70) P<0.01
aNS. not signifIcant.
howexver. no significant differences in the extent of infiltration bv
DCs among clinical stages (Table 31.
DISCUSSION
Dendritic cells are the most effectix e antigen-presenting cells
(APCs) in the induction of the primary immune responses to
cancer cells. DCs belong to a monocy-te-macrophage lineage.
Most cells of the monocvte-macrophage lineage express CD14
and CD68 molecules. DCs do not express these molecules but do
strongly express HLA-DR and S-100 protein (Furukawa et al.
1984). Therefore. we determined the extent of infiltration bv DCs
of gastric carcinoma tissues immunohistochemicall. usine a
monoclonal antibodv against S-100 protein. to rain some idea of
the extent ofthe local immune response.
The densitx ofDCs correlated with prognosis in both stage II and
stage III disease but did not correlate in stage I or IV In the previous
studv. the density ofDCs correlated w-ith prognosis only in stage III.
In the current study. we analysed different patients from previous
studies and applied a new classification for gastric cancer to our
patients (Japanese Research Society for Gastric Cancer. 1995).
Thus. the present results might be different from our previous
results. Moreover. the prognosis ofpatients w-ith marked infiltration
by DCs was significantly better than that of patients with slight
infiltration by DCs in patients ,Aho had undergone curative gastrec-
tomv. Multivariate analx sis showed that the infiltration bv DCs w-as
an independent prognostic indicator in the current study.
With regard to the factors that determine the densitv of DCs. no
significant correlation w-as found between the density of DCs and
pattems ofDNA ploidy. w-hich represent the malignant potential of
gastric tumours (Kakeji et al. 1993). The potential for nodal
spreading appears to be associated w-ith the g-rowth potential of
tumour cells and w-ith the local immune status (Maehara et al.
1997). The former Aas ex aluated on the basis of levels ofprolifer-
ating cell nuclear antigen (PCNA) and the latter on the basis of
infiltration by DCs. The PCNA labelling index and the extent of
infiltration bv DCs wxere inxerselx related. These results suggest
that decreased infiltration bv DCs might be induced bv cvtokines.
such as transforming growth factor beta (TGF-1). w-hich are
produced by tumour cells A-ith a high agrowth potential (KekoA- et
al. 1995). How-exver. the influence oftumour cells on the densitv of
DCs is still unclear.
Gabriloxich et al (1996b) reported that supematants of extracts
of tumour cells in model tumour svstems in animals inhibit the
functional maturation of DCs. and thex recently identified VEGF
as being, directly responsible for the inhibition ofthe maturation of
DCs from CD34- precursors. The presence of mRNA specific for
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both Kdr and Flt1. w-hich are receptors for VEGF. in CD34-
precursors (Katoh et al. 1995) suggests that these cells might be
affected by VEGF. Therefore. we investigated whether the expres-
sion of VEGF might correlate with the density of S-100 protein-
positiv-e DCs in human gastric adenocarcinoma.
Numerous studies have demonstrated that the expression ofVEGF
is a significant predictor ofan increased risk ofmetastatic disease. as
well as of overall survival by stimulating angiogenesis in gastric
carcinoma (Maeda et al. 1996). oesophageal carcinoma (Inoue et al.
1997). breast carcinoma (Toi et al. 1994) and non-small-cell lung
carcinoma (Fontanini et al. 1997). We also found that the prognosis
ofpatients whose tumours expressed VEGF was significantly w-orse
than that of patients whose tumours did not express VEGF. among,
patients who had undergone curative gastrectomy.
In the present study. the expression of VEGF w-as found to be
inversely related to the densitv of DCs in gastric carcinoma
Moreover. the number of S-100 protein-positive DCs in VEGF-
ne2ative tumours was significantly higher than that in VEGF-
positive tumours in patients with gastric carcinoma at stages I. II and
111. Even at stage I'. the number of S-100 protein-positive DCs in
VEGF-negative tumours was higher than that in VEGF-positive
tumours. but the difference was not significant. Thus. the expression
of VEGF might not only be correlated with angiogenesis. which
plays an important role in the progression and prognosis of solid
tumours. but it might also help tumours to avoid inducing a local
immune response. VEGF might play a broader role in the progres-
sion ofaastric cancer than has previously been considered likelv. Our
findings show. for the first time. that the density of S-100 protein-
positive DCs in primary gastric carcinoma might be controlled or
influenced by VEGF. On the other hand. no data on immune compe-
tence. such as responsiveness to skin antigen testing and recall
responses to tetanus toxoid. were recorded in our patients. Further
studies are necessarv toclarify the correlation between the expression
ofVEGF and immunity in patients with gastric carcinoma.
Antiangiogenic agents have received attention in clinical
oncolooy as potential therapeutic agrents (O Reilly et al. 1994).
TNP470 is a synthetic analogue of fumagillin with stronc anti-
angiogenic activity: it inhibits tumour growth and metastasis in
experimental models (Yamaoka et al. 1993: Yanase et al. 1993). A
therapeutic blockade of the action of VEGF might improve
prospects for immunotherapy. and it might also inhibit neovascu-
larization oftumours.
In conclusion. expression of VEGF in castric adenocarcinomas
was associated with a decrease in the density ofS-100 protein-posi-
tive DCs. Thus. VEGF might be associated with the progression of
tumours and prognosis. not only via angiogenesis but also via
avoidance of the induction of an immune response. Therapeutic
blockade of the action of VEGF could conceivablv provide a new
treatment modality for patients with metastatic tumours.
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